To view this email as a web page, click here.
 
Cancer risk found with common blood pressure med
Pharma makers are voluntarily recalling several drugs containing this active ingredient used to treat high blood pressure and heart failure, since they may contain a carcinogen.
Read more
 
Broader indication for prostate cancer drug could net billions of dollars
FDA’s approval of an expanded indication for a prostate cancer drug could net 2 pharmaceutical manufacturers billions of dollars.
Read more
 
Cancer drug prices rise despite Trump plan
The manufacturer of 2 cancer drugs hiked the price on the medicines, despite President Donald Trump’s new plan to lower drug prices.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.